Picture of Dr Reddy's Laboratories logo

RDY Dr Reddy's Laboratories Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Dr Reddy's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue154,482175,170190,475215,452246,697
Cost of Revenue
Gross Profit104,686115,044124,828135,480163,649
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses134,048162,030164,022189,427194,498
Operating Profit20,43413,14026,45326,02552,199
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes22,92018,85728,83530,61460,485
Provision for Income Taxes
Net Income After Taxes19,06520,21919,20321,78145,073
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income19,50020,26019,51621,82545,073
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income19,50020,26019,51621,82545,073
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS112188143166279
Dividends per Share